Clinlab Navigator

TSH

Thyrotropin releasing hormone (TRH), a hypothalamic peptide, stimulates the anterior pituitary to synthesize and secrete thyroid stimulating hormone (TSH). TSH stimulates the release of triiodothyronine (T3) and thyroxine (T4₎ from thyroglobulin and their secretion by the thyroid.

The introduction of sensitive TSH assays has transformed thyroid function testing from a thyroxine to a TSH based strategy. The sensitivity of TSH assays has greatly improved. The functional sensitivity is 0.1 mIU/L for second generation assays and 0.01 for third generation assays. The major advantage of third generation assays is better precision at 0.1 mIU/L, which is the recommended cutoff for consideration of hyperthyroidism. Third generation assays are also preferred for monitoring thyroid replacement therapy after thyroid ablation.

The American Thyroid Association recommends the combined use of TSH and free T4 as the most efficient combination of blood tests for diagnosis and follow-up of both ambulatory and hospitalized patients. Testing begins with TSH, because it is the most sensitive indicator of thyroid metabolism in patients with normal pituitary gland function. TSH usually shifts out of the normal range sooner than thyroxine or freeT4. Linear changes in free T4 concentration result in logarithmic changes in TSH secretion. About 85% of patients have normal TSH values and do not require further testing.

Decreased TSH values suggest primary hyperthyroidism, exogenous hyperthyroxinemia, or the effect of glucocorticoids. Hyperthyroidism is caused by too much circulating T4. Graves’s disease, is an autoimmune disorder caused by antibody to TSH receptors, which leads to uncontrolled release of T4 and T3 and suppression of circulating TSH. Subsequent measurement of freeT4 serves as an index of the severity of hyperthyroidism because TSH levels can be suppressed even by small increases in FT4. Serum T4, free T4, T3, and free T3 concentrations are elevated two to three times above the upper limit of normal and TSH is undetectable. If FT4 is normal, total or free T3 should be measured to detect T3 toxicosis.

Increased TSH levels suggest primary hypothyroidism, which is the most common thyroid disorder. In this condition, the thyroid fails to respond to TSH. The pituitary secretes more TSH in response to decreasing circulating T4 concentrations. The failing thyroid gland partially compensates by increasing the ratio of secreted T3 to T4. If this last attempt to restore homeostasis fails, the patient’s metabolic rate falls. At this stage of hypothyroidism, TSH is elevated and T4 and free T4 are decreased. Normal free T4 levels are consistent with subclinical hypothyroidism, which can be confirmed by testing for thyroid peroxidase antibodies. Other rare causes of elevated TSH include a pituitary adenoma and thyroid hormone resistance.

The following medications may increase TSH levels: dopamine antagonists, chlorpromazine, haloperidol, and iodine containing drugs. TSH may be decreased by exogenous thyroxine, glucocorticoids, dopamine, levodopa, dopamine agonists,apomorphine, and pyridoxine.

Nonthyroid illness and poor nutrition can cause many aberrations in pituitary and thyroid function. Seventeen percent of hospitalized adults have abnormal elevations or depression of TSH. In general, the more severe the illness, the more abnormal the tests. In critically ill patients, especially those receiving dopamine, TSH production is often reduced. As the illness progresses, T4 production is also reduced. A smaller group of patients with nonthyroid illness have increased serum T4 levels.

Although there is a consensus that the lower limit of the euthyroid reference range for TSH should be 0.2-0.4 mIU/L, there is still disagreement about where the upper limit should be set. For many years, endocrinologists considered TSH levels >10 mIU/L to be evidence of thyroid failure and levels between 5 and 10 mIU/L to be evidence of mild or subclinical hypothyroidism. However, the upper reference limit for TSH has steadily declined from 10 to 4.5 mIU/mL because of improvements in TSH assays and the elimination of subjects with thyroid peroxidase antibodies from the population used to determine the reference range.

The median TSH level in the general population is 1.5 mIU/mL, which is considerably below the 4.5 uIU/mL upper limit of normal reported by most laboratories. More than 95% of rigorously screened euthyroid volunteers have TSH values between 0.4 and 2.5. Individuals with a TSH >2.0 have an increased odds ratio of developing hypothyroidism. Many endocrinologists believe that a TSH result above 3.0 mIU/mL is abnormal, regardless of the fT4 result.

The National Academy of Clinical Biochemistry has recommended lowering the upper limit of the TSH reference range to 4.0 mIU/L, while the American Association of Clinical Endocrinologists has set the upper limit at 3.0 mIU/L. Other experts feel the upper limit of normal should be lowered even further to 2.5 mIU/L.

The median TSH level increases with age, starting at about age 50, in a disease free population.

 

Serum TSH levels exhibit considerable diurnal variation, with a maximum level occurring around midnight. TSH levels decrease as much as 50% by 08:00 to 09:30 a.m. The concentration then remains relatively constant until evening, with a smaller nadir in the late afternoon. Because of this significant diurnal variation, sequential specimens should be drawn at the same time of day.

TSH can normally fluctuate as much as 19% during a one week period within an individual. If a patient has a true TSH of 3.0 mIU/L, their 95% confidence interval ranges from 1.4 to 4.6 mIU/mL. Unexpected TSH results may be explained by this normal biological variation.

Specimen requirement is one red top tube of blood.